Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Solstice Capital

Investor type Micro VC
Founders Harry George Henry Newman

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 47
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 23
Rounds per year 1.74
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.51
Exits 17
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Software
  • Health Care
  • Manufacturing
  • Medical
Summary

Solstice Capital appeared to be the VC, which was created in 1995. The company was established in North America in United States. The leading representative office of defined VC is situated in the Salem.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Solstice Capital, startups are often financed by Valley Ventures, Village Ventures, Polaris Partners. The meaningful sponsors for the fund in investment in the same round are Village Ventures, Polaris Partners, Commons Capital. In the next rounds fund is usually obtained by Valley Ventures, North Bridge Venture Partners & Growth Equity, Intel Capital.

This Solstice Capital works on 8 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in 2-6 investment rounds annually. The increased amount of exits for fund were in 2015. The real fund results show that this VC is 11 percentage points less often commits exit comparing to other companies. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2005.

Among the various public portfolio startups of the fund, we may underline PhotoThera, Sequencia, Regenesis Biomedical The fund has exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Security.

This organization was formed by Harry George, Henry Newman. Besides them, we counted 2 critical employees of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Solstice Capital:
Typical Co-investors
Solstice Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Solstice Capital:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Splash Pharmaceuticals

Biotechnology
Pharmaceutical
21 May 2018 San Diego, California, United States

HTG Molecular Diagnostics

Biotechnology
Genetics
Health Diagnostics
Life Science
Medical
$16M13 Jul 2011 Tucson, Arizona, United States

Regenesis Biomedical

Biotechnology
Health Care
Medical Device
Wellness
$5M06 Jun 2011 Scottsdale, Arizona, United States

HTG Molecular Diagnostics

Biotechnology
Genetics
Health Diagnostics
Life Science
Medical
$2M28 Nov 2008 Tucson, Arizona, United States

CodeRyte

Health Care
Medical
Natural Language Processing
Software
$13M14 Nov 2008 Bethesda, Maryland, United States

Regenesis Biomedical

Biotechnology
Health Care
Medical Device
Wellness
$2M22 May 2008 Scottsdale, Arizona, United States

Lumidigm

Biometrics
Identity Management
Network Security
Point of Sale
$7M29 Jan 2008 Albuquerque, New Mexico, United States

AmpliMed Corporation

Biotechnology
Health Care
Therapeutics
$5M14 Jan 2008 Tucson, Arizona, United States

HTG Molecular Diagnostics

Biotechnology
Genetics
Health Diagnostics
Life Science
Medical
$5M08 Oct 2007 Tucson, Arizona, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Solstice Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: